Abstract:
:Patients with systemic lupus erythematosus (SLE) frequently have gastrointestinal (GI) symptoms. These are usually self-limiting and related to treatment side-effects or concurrent illness. However, abdominal pain may be due to bowel ischaemia which can lead to infarction and perforation. The likelihood of these serious events is increased in individuals with pain severe enough to require assessment in hospital or a SLEDAI score > 5. This paper describes a group of patients with active SLE and GI symptoms severe enough to require admission to hospital using a retrospective review of 52 SLE patients admitted to hospital with acute abdominal symptoms. The results showed that abdominal pain (87%), vomiting (82%) and diarrhoea (67%) had been present for a mean of 4.4 +/- 6.5 days and SLEDAI score was > or = 4 in 83% of patients. CT scanning showed evidence of serositis and bowel involvement in 63% of patients who underwent this investigation. Intravenous (iv) fluids were used in 87%, parenteral steroids in 90% and iv cyclophosphamide in 31%. Most (n = 51) were discharged well. Recurrence of GI symptoms occurred in 12 patients. The conclusions are that active SLE may manifest as an acute gastrointestinal syndrome. Early diagnosis, bowel rest, supportive medical therapy and treatment with corticosteroids and/or immunosupressives can result in a good outcome.
journal_name
Lupusjournal_title
Lupusauthors
Lian TY,Edwards CJ,Chan SP,Chng HHdoi
10.1191/0961203303lu433oasubject
Has Abstractpub_date
2003-01-01 00:00:00pages
612-6issue
8eissn
0961-2033issn
1477-0962journal_volume
12pub_type
杂志文章相关文献
LUPUS文献大全abstract::Legionnaire's disease (LD) is most commonly caused by Legionella pneumophila (L. pneumophila). In immunocompromised patients LD can cause necrosis of the lung parenchyma with abscess formation and cavitation. Systemic lupus erythematosus (SLE) is an autoimmune disorder with features of both primary and secondary immun...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203321990102
更新日期:2021-01-26 00:00:00
abstract::Atherosclerosis is an inflammatory disease, leading to the formation of pro-inflammatory and pro-oxidative lipids that generate an immune response. Several antigens have been shown to activate the immune response and affect the development of atherogenesis. Systemic lupus erythematosus is an autoimmune and inflammator...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203309345725
更新日期:2009-11-01 00:00:00
abstract:BACKGROUND:Patients with systemic lupus erythematosus (SLE) are at a high risk for cardiovascular disease (CVD) due to increased prevalence of traditional and nontraditional CVD risks factors. OBJECTIVE:To evaluate the effect of patient-centered nutrition counseling methods on changes in select nutrient, anthropometri...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203315582284
更新日期:2015-10-01 00:00:00
abstract::The aim of this study was to investigate two patients with antiphospholipid syndrome (APS) who suffered from multiple repeated pregnancy losses of probably genetically impaired embryos. Sera from these patients contained high levels of IgG antibodies against cardiolipin, IgG and IgM phosphatidyl inositol, IgG phosphat...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203312442581
更新日期:2012-06-01 00:00:00
abstract::Mesenchymal stem cells have been applied to treat graft versus host disease as they have immunosuppressive ability and can overcome the major histocompatibility complex-histocompatibility barrier. The potential of allogeneic mesenchymal stem cells in treating systemic lupus erythematosus (SLE) was investigated in this...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320928419
更新日期:2020-07-01 00:00:00
abstract:OBJECTIVE:To investigate the predictive value of serum C3 and C4 complement component levels in relation to pregnancy outcome in patients with antiphospholipid syndrome (APS). MATERIALS AND METHODS:A prospective study of 47 pregnancies associated with APS was performed. Pregnancy outcome was analyzed in terms of: feta...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203312444172
更新日期:2012-06-01 00:00:00
abstract::Systemic lupus erythematosus may present with renal manifestations that frequently are difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type and spectrum of renal injury may remain undiagnosed until full-blown nephritic and/or nephrotic syndrome appear with increased risk of e...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203309358187
更新日期:2010-04-01 00:00:00
abstract::The purpose of the present study was to evaluate patients with the antiphospholipid syndrome with particular attention to their initial clinical features, final diagnoses and the course of thrombotic events in association with therapy. The methodology applied was the following: retrospective analysis of 30 patient fil...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339400300206
更新日期:1994-04-01 00:00:00
abstract::In vitro data showed that immunoglobulin G (IgG) from lupus nephritis (LN) patients could bind to proximal renal tubular epithelial cells (PTEC), but the clinical relevance of such binding remained unclear. Binding of IgG and subclasses to PTEC was measured by cellular ELISA (expressed as OD index) in 189 serial serum...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203315598018
更新日期:2016-01-01 00:00:00
abstract::Gastrointestinal manifestations of systemic lupus erythematosus (SLE) are common, occurring in about 50% of cases. They are usually mild, in the form of mouth ulcers, nausea, heartburn and mild abdominal pain, but they can be severe in cases of gastrointestinal vasculitis. In this report we describe an unusual combina...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203313517150
更新日期:2014-02-01 00:00:00
abstract::Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production o...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203314560207
更新日期:2015-03-01 00:00:00
abstract::We performed a retrospective study of all systemic lupus erythematosus (SLE) pregnancies during a two-year period (2006-2007) to describe the clinical features, maternal and foetal outcomes in our centre. There were 17 pregnancies in 16 women with SLE. Our patients have a mean age of 28.31 years (SD 5.24) and a mean d...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203308096661
更新日期:2009-03-01 00:00:00
abstract::Objectives We analyzed the clinical follow-up results of 88 lupus nephritis patients to find prognostic factors for the development of chronic kidney disease in ethnically homogeneous Korean patients with biopsy-proven lupus nephritis. Methods Sociodemographic, clinical, laboratory, and treatment-related data at the t...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203317694257
更新日期:2017-10-01 00:00:00
abstract:OBJECTIVE:The aim of this study was to determine whether the functional CD40 rs4810485 G/T polymorphism is associated with susceptibility to rheumatoid arthritis (RA) or with susceptibility to systemic lupus erythematosus (SLE). METHODS:A series of meta-analyses were conducted to test for association between the CD40 ...
journal_title:Lupus
pub_type: 杂志文章,meta分析
doi:10.1177/0961203315583543
更新日期:2015-10-01 00:00:00
abstract:Background:Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Tha...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320911091
更新日期:2020-05-01 00:00:00
abstract::Only recently Bartonella species have been recognized as important human pathogens. Cat scratch disease (CSD), caused by infection with Bartonella henselae, shows a steady increase in the number of cases throughout the world. We report a case of an 18-year-old woman with systemic lupus erythematosus (SLE) who presente...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/096120301701548373
更新日期:2001-01-01 00:00:00
abstract::The aim of the study is to investigate whether the functional p53 codon 72 polymorphism is associated with susceptibility to SLE and its clinical features. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 90 SLE patients and 114 ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/0961203305lu2224oa
更新日期:2005-01-01 00:00:00
abstract::Background and objective African-Americans and Hispanic-Americans with lupus are the two most common minority groups who receive kidney transplants in the USA. It is unknown if African-Americans and Hispanic-Americans with lupus have similar outcomes after kidney transplantation. In this study, we assessed whether Afr...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203317699287
更新日期:2017-10-01 00:00:00
abstract::Therapeutic agents currently in use to treat systemic lupus erythematosus (SLE) are predominantly immunosuppressive agents with limited specificities. Multiple groups, including ours, have illustrated that inducing tolerance in SLE animal models ameliorates disease symptoms and increases survival. We examined if oral ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203311398509
更新日期:2011-08-01 00:00:00
abstract::Nephropathy of antiphospholipid antibody syndrome (NAPS) is an increasingly well-recognized aspect of antiphospholipid syndrome. The most characteristic histopathology is that of thrombotic microangiopathy, and thrombosis occurring in the renal vasculature is thought to be the initiating event. Other less common patho...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203308098629
更新日期:2009-05-01 00:00:00
abstract::We report the experience from the Antiphospholipid Antibodies (aPL) Regional Consortium in northwest Italy, meant to support clinical research and foster collaboration among health professionals regarding the diagnosis and management of antiphospholipid syndrome (APS) patients. This cohort-study (APS Piedmont Cohort) ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203312446974
更新日期:2012-06-01 00:00:00
abstract::Lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) is a rare acquired disorder caused by prothrombin antibodies. The disease is most common in the pediatric age group (<16 years), and more prevalent in women. There are well-established clinical diseases associated with LA-HPS, most notably systemic lupus erythe...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203314558859
更新日期:2015-06-01 00:00:00
abstract::Central nervous system (CNS) involvement may occur in 20-70% of systemic lupus erythematosus (SLE) patients where neurological symptoms are overt; this is termed neuropsychiatric lupus or NPSLE. This review summarizes evidence that damage to the brain endothelium forming the blood-brain barrier (BBB) is a contributory...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1191/0961203303lu501oa
更新日期:2003-01-01 00:00:00
abstract::A girl with neuropsychiatric lupus demonstrated Parkinsonian features soon after commencing risperidone. The single photon emission computed tomography scan showed hyperperfusion of the basal ganglia. Symptoms abated with the addition of dopaminergic agents to immunosuppressive therapy. The literature on juvenile Park...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203307081421
更新日期:2007-01-01 00:00:00
abstract:BACKGROUND:GlycA is a novel marker of systemic inflammation detected by nuclear magnetic resonance (NMR) spectroscopy. In the general population, GlycA is correlated with inflammatory markers such as C-reactive protein (CRP) and associated with coronary heart disease and diabetes. The utility of GlycA in patients with ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203315617842
更新日期:2016-03-01 00:00:00
abstract::We report a woman with systemic lupus erythematosus (SLE) with diffuse proliferative glomerulonephritis and anti-dsDNA antibodies whose serum contained autoantibodies specific for the phosphorylated form of RNA polymerase II (RNAP IIO), Su and ribosomal P antigen, as well as anti-topoisomerase I antibodies, a marker f...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339500400414
更新日期:1995-08-01 00:00:00
abstract:BACKGROUND:Ferritin is an iron storage protein considered also as an acute phase reactant with high levels in various inflammatory conditions. Recently, a plausible role for ferritin in the pathogenesis of immune-mediated and especially autoimmune diseases has been suggested. However, the link between ferritin and the ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203313504633
更新日期:2013-11-01 00:00:00
abstract::In this study, we report the case of a Chinese patient with systemic lupus erythematosus (SLE) who developed neutropenia after treatment by olanzapine for the SLE-related psychiatric symptoms. The relationship between agranulocytosis, SLE and olanzapine is still unknown. Fcγ receptor IIIb (FcγRIIIb) is a low-affinity ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203311415889
更新日期:2012-01-01 00:00:00
abstract::Novel risk factors for the progression of atherosclerosis such as C-reactive protein (CRP) and adhesion molecules have stimulated much recent interest in the role of inflammation in atherosclerotic disease. There is also evidence emerging that autoimmunity may have a role in the pathogenesis of atherosclerosis. In thi...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1191/096120301680416922
更新日期:2001-01-01 00:00:00
abstract:OBJECTIVE:To describe clinical effectiveness of belimumab for systemic lupus erythematosus (SLE) in real-world practice in Argentina. METHODS:This retrospective, observational study analysed medical record data of patients with SLE treated with belimumab in 15 centres in Argentina. Primary endpoint: overall clinical r...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203320947814
更新日期:2020-10-01 00:00:00